30 June 2020 : Clinical Research
Application of the Molecular Adsorbent Recirculating System in Type 1 Hepatorenal Syndrome in the Course of Alcohol-Related Acute on Chronic Liver Failure
Grzegorz Kade1ABCEF, Arkadiusz Lubas1ACDEF, Sebastian Spaleniak2ADEF*, Anna Wojtecka1B, Ksymena Leśniak1B, Sławomir Literacki3BF, Stanisław Niemczyk1E, Przemysław Dyrla4BCDEDOI: 10.12659/MSM.923805
Med Sci Monit 2020; 26:e923805
Table 5 Comparison of the effectiveness of MARS treatments in West Haven and MELD-Na score results.
| Variable | Before MARS | After MARS | ||
|---|---|---|---|---|
| Mean | SD | Mean | SD | |
| West Haven | 1.6 | 0.9 | 1.1 | 1.4 |
| West Haven – s | 1.0 | 0.0 | 0.0 | 0.0 |
| West Haven – ns | 2.2 | 0.8 | 2.2 | 1.3 |
| MELD-Na | 34.9 | 5.2 | 35.1 | 6.9 |
| MELD-Na – s | 38.0 | 4.9 | 29.2 | 3.8 |
| MELD-Na – ns | 31.8 | 3.4 | 41.0 | 2.4 |
| MARS – Molecular Adsorbent Recirculating System; MELD-Na pre/post – model for end-stage liver disease; s – survival; ns – non-survival; SD – standard deviation. | ||||